Current Liabilities
Accrued Liabilities, Current
Boston Scientific Accrued Liabilities, Current increased by 7.4% to $3.20B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 15.4%, from $2.77B to $3.20B. Over 5 years (FY 2020 to FY 2025), Accrued Liabilities, Current shows an upward trend with a 7.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
A steady increase relative to revenue may indicate rising operational costs or changes in payment timing.
Detailed definition
These are short-term obligations for expenses that have been incurred but not yet invoiced or paid by the end of the rep...
Peer comparison
Standard across all industries for tracking short-term operational obligations.
Metric ID:
current_liabilities_accrued_liabilities_currentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.44B | $2.42B | $2.44B | $2.31B | $2.20B | $1.97B | $2.16B | $1.92B | $2.16B | $2.26B | $2.65B | $2.08B | $2.32B | $2.46B | $2.77B | $2.35B | $2.80B | $2.98B | $3.20B |
| QoQ Change | — | -1.0% | +0.7% | -5.3% | -4.7% | -10.2% | +9.4% | -11.2% | +12.8% | +4.2% | +17.3% | -21.3% | +11.4% | +6.0% | +12.7% | -15.1% | +18.8% | +6.6% | +7.4% |
| YoY Change | — | — | — | — | -10.0% | -18.4% | -11.3% | -16.8% | -1.5% | +14.2% | +22.5% | +8.6% | +7.2% | +9.1% | +4.8% | +13.0% | +20.6% | +21.2% | +15.4% |
Range$1.92B – $3.20B
CAGR+6.2%
Avg YoY Growth+5.2%
Median YoY Growth+8.6%
Current Streak3 quarters growth
Accrued Liabilities, Current at Other Companies
Frequently Asked Questions
- What is Boston Scientific's accrued liabilities, current?
- Boston Scientific (BSX) reported accrued liabilities, current of $3.20B in Q4 2025.
- How has Boston Scientific's accrued liabilities, current changed year-over-year?
- Boston Scientific's accrued liabilities, current increased by 15.4% year-over-year, from $2.77B to $3.20B.
- What is the long-term trend for Boston Scientific's accrued liabilities, current?
- Over 5 years (2020 to 2025), Boston Scientific's accrued liabilities, current has grown at a 7.8% compound annual growth rate (CAGR), from $2.20B to $3.20B.
- What does accrued liabilities, current mean?
- Short-term expenses that have been incurred but not yet paid.